Article

Diagnostic Test Accuracy of Commercially Available Tests for The Recurrence of Bladder Cancer: A Systematic Review and Meta-Analysis

2026-02-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> Bladder cancer (BC) is the most common malignancy of the urinary system and among the most frequently diagnosed cancers worldwide. This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of commercially available urinary biomarkers tests (UBTs) for detecting BC recurrence, focusing on pooled sensitivity and specificity estimates across different tes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2c583dc1-489f-5d51-a7db-5631815264f3
DOI: 10.64898/2026.02.02.26344871

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Diagnostic Test Accuracy of Commercially Available Tests for The Recurrence of Bladder Cancer: A Systematic Review and Meta-AnalysisDOI 10.64898/2026.02.02.26344871Read

Uromonitor®: Clinical Validation and Performance Assessment of a Urinary Biomarker for Recurrence Surveillance in Non-Muscle Invasive Bladder Cancer PatientsSemantic proximity Read

Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical PathwaysSemantic proximity Read

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity Read

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read

Uromonitor: Clinical Validation and Performance Assessment of a Urinary Biomarker Within the Surveillance of Patients With Nonmuscle-Invasive Bladder Cancer.Semantic proximity Read

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter StudySemantic proximity Read

GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria ClinicsSemantic proximity Read

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.Semantic proximity Read

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder CancerSemantic proximity Read